Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,157 | -59,517 | -46,014 | -31,315 | -15,925 |
| Depreciation Amortization | 203 | 830 | 628 | 424 | 212 |
| Accounts payable and accrued liabilities | -905 | -4,545 | -4,240 | -2,876 | -1,678 |
| Other Working Capital | -764 | -4,780 | -3,546 | -2,041 | -1,037 |
| Other Operating Activity | 3,685 | 16,184 | 12,856 | 8,529 | 4,423 |
| Operating Cash Flow | $-12,938 | $-51,828 | $-40,316 | $-27,279 | $-14,005 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -46 | -37 | -31 | -18 |
| Investing Cash Flow | $-5 | $-46 | $-37 | $-31 | $-18 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 145,999 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 163 | -77 | -77 | -77 |
| Financing Cash Flow | $145,999 | $163 | $-77 | $-77 | $-77 |
| Beginning Cash Position | 59,050 | 110,761 | 110,761 | 110,761 | 110,761 |
| End Cash Position | 192,106 | 59,050 | 70,331 | 83,374 | 96,661 |
| Net Cash Flow | $133,056 | $-51,711 | $-40,430 | $-27,387 | $-14,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,938 | -51,828 | -40,316 | -27,279 | -14,005 |
| Capital Expenditure | -5 | -46 | -37 | -31 | -18 |
| Free Cash Flow | -12,943 | -51,874 | -40,353 | -27,310 | -14,023 |